SOTIO Trademark

Trademark Overview


On Thursday, August 10, 2017, a trademark application was filed for SOTIO with the United States Patent and Trademark Office. The USPTO has given the SOTIO trademark a serial number of 79218559. The federal status of this trademark filing is REGISTERED as of Tuesday, October 9, 2018. This trademark is owned by SOTIO a.s.. The SOTIO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals, medical and veterinary preparations for the treatment of oncological, immune and autoimmune diseases; anticancer preparations; antitumor drugs; vaccines; anticancer vaccines; synthetic peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs all for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; biological preparations for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; cellular preparations for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; biological tissue from blood or bone marrow intended for subsequent implantation; radiopharmaceutical preparations for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and diabetes; clinical diagnostic reagents for medical or veterinary purposes; diagnost...

Medical services; medical diagnostic services for diagnostic or treatment purposes

Scientific services, namely, research and design in the field of antineoplastic and immunomudulating agents relating thereto; industrial analysis and research services in the field of pharmaceuticals and biotechnology; scientific research for medical and veterinary purposes in the field of oncological, immune and autoimmune diseases ; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases or diabetes; pharmaceutical drug development services; conducting clinical trials for others; preclinical and clinical research in the field of oncological, immune and autoimmune diseases; analysis of toxicology and mode of action of biologicals, chemicals and combinations on animals, namely, toxicology services; pharmaceutical and biological product research, development, safety, efficacy and quality control testing services; scientific research and development for diagnostic purposes; computer-aided diagnostic testing services, ...
sotio

General Information


Serial Number79218559
Word MarkSOTIO
Filing DateThursday, August 10, 2017
Status700 - REGISTERED
Status DateTuesday, October 9, 2018
Registration Number5577770
Registration DateTuesday, October 9, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements


Goods and ServicesPharmaceuticals, medical and veterinary preparations for the treatment of oncological, immune and autoimmune diseases; anticancer preparations; antitumor drugs; vaccines; anticancer vaccines; synthetic peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs all for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; biological preparations for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; cellular preparations for the treatment of oncological, immune and autoimmune diseases for medical and veterinary purposes; biological tissue from blood or bone marrow intended for subsequent implantation; radiopharmaceutical preparations for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and diabetes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic agents, preparations and diagnostic kits comprised of medical diagnostic reagents, sample collection devices in the nature of specimen cups and tubes, and instructions for testing of bodily fluids and tissues for use in testing and detection of oncological, immune or autoimmune diseases for medical and veterinary purposes; drug delivery agents in the form of dissolvable tablets, capsules, gels, micelles, liposomes, particles, nanoparticles, ointment and creams, that facilitate the delivery of pharmaceutical preparations; adjuvants for medical use; dietetic substances adapted for medical use, namely, food and beverages
Goods and ServicesMedical services; medical diagnostic services for diagnostic or treatment purposes
Goods and ServicesScientific services, namely, research and design in the field of antineoplastic and immunomudulating agents relating thereto; industrial analysis and research services in the field of pharmaceuticals and biotechnology; scientific research for medical and veterinary purposes in the field of oncological, immune and autoimmune diseases ; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases or diabetes; pharmaceutical drug development services; conducting clinical trials for others; preclinical and clinical research in the field of oncological, immune and autoimmune diseases; analysis of toxicology and mode of action of biologicals, chemicals and combinations on animals, namely, toxicology services; pharmaceutical and biological product research, development, safety, efficacy and quality control testing services; scientific research and development for diagnostic purposes; computer-aided diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management in the fields of oncology and autoimmune disease and cancer and autoimmune research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 20, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 20, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSotio Biotech a.s
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCZ

Party NameSOTIO a.s.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCZ

Party NameSOTIO a.s.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCZ

Party NameSOTIO a.s.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCZ

Trademark Events


Event DateEvent Description
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, November 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 11, 2022CHANGE OF OWNER RECEIVED FROM IB
Friday, December 3, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 3, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 3, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 3, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 3, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 21, 2020NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, September 18, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 18, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 15, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 24, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 24, 2019FINAL DISPOSITION PROCESSED
Wednesday, January 9, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, December 27, 2018NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 9, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Friday, July 20, 2018NOTIFICATION PROCESSED BY IB
Wednesday, July 4, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 4, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, June 21, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 15, 2018EXAMINER'S AMENDMENT ENTERED
Friday, June 15, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 15, 2018EXAMINERS AMENDMENT E-MAILED
Friday, June 15, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 1, 2018ASSIGNED TO LIE
Tuesday, May 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 22, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 22, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, December 17, 2017REFUSAL PROCESSED BY IB
Monday, November 27, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 27, 2017REFUSAL PROCESSED BY MPU
Tuesday, November 14, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 13, 2017NON-FINAL ACTION WRITTEN
Monday, November 13, 2017ASSIGNED TO EXAMINER
Tuesday, October 24, 2017APPLICATION FILING RECEIPT MAILED
Friday, October 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 19, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB